Advanced Search
Share
Current Issue
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Case Report
Primary refractory B-cell lymphoblastic leukemia with extramedullary disease – a distinctive response to blinatumomab and inotuzumab ozogamicin
Wellington Fernandes da Silvaa,
Corresponding author
wellington.fernandes@hc.fm.usp.br

Corresponding author at: Instituto do Câncer do Estado de São Paulo (ICESP), Av. Dr. Arnaldo, 251, Cerqueira César, São Paulo CEP 01246-000, SP, Brazil.
, Gabriel Lacerda Marqueza, Rafael Calil Salima, Vanderson Rochaa,b
a Instituto do Câncer do Estado de São Paulo (ICESP), Universidade de São Paulo, São Paulo, SP, Brazil
b Churchill Hospital, Oxford University NHS-BT, Oxford, United Kingdom
Read
3826
Times
was read the article
1259
Total PDF
2567
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
DOI:10.1016/j.htct.2018.11.004
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 21 11 32
2024 March 42 18 60
2024 February 39 25 64
2024 January 28 20 48
2023 December 26 21 47
2023 November 40 26 66
2023 October 41 25 66
2023 September 41 28 69
2023 August 32 16 48
2023 July 55 7 62
2023 June 56 22 78
2023 May 58 14 72
2023 April 37 6 43
2023 March 63 19 82
2023 February 42 12 54
2023 January 47 13 60
2022 December 53 20 73
2022 November 48 21 69
2022 October 60 20 80
2022 September 52 21 73
2022 August 73 27 100
2022 July 58 25 83
2022 June 38 16 54
2022 May 42 23 65
2022 April 39 26 65
2022 March 53 26 79
2022 February 65 18 83
2022 January 77 21 98
2021 December 35 21 56
2021 November 51 33 84
2021 October 55 32 87
2021 September 41 29 70
2021 August 64 33 97
2021 July 44 29 73
2021 June 46 28 74
2021 May 50 34 84
2021 April 69 55 124
2021 March 50 22 72
2021 February 39 15 54
2021 January 43 19 62
2020 December 18 14 32
2020 November 31 13 44
2020 October 26 6 32
2020 September 24 19 43
2020 August 40 17 57
2020 July 19 10 29
2020 June 31 16 47
2020 May 32 22 54
2020 April 29 13 42
2020 March 23 9 32
2020 February 42 22 64
2020 January 48 36 84
2019 December 30 19 49
2019 November 51 23 74
2019 October 42 12 54
2019 September 34 25 59
2019 August 36 14 50
2019 July 26 11 37
2019 June 24 17 41
2019 May 17 18 35
2019 April 21 19 40
2019 March 10 7 17
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Special content about COVID-19
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
Idiomas
Hematology, Transfusion and Cell Therapy